By interrogating publicly available MYCN ChIP-seq data (GSE138295), we found that endogenous MYCN binds to the promoter of the KAT2A gene in all these MYCN-amplified NB cell lines (Fig. 2E). The gene discussed is KAT2A; the disease is neuroblastoma.